BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 991 filers reported holding BAXTER INTL INC in Q3 2022. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,621,153 | -16.1% | 95,950 | +1.3% | 0.01% | -9.1% |
| Q2 2023 | $4,317,037 | -49.2% | 94,755 | -54.8% | 0.01% | -47.6% |
| Q1 2023 | $8,495,779 | +82826.1% | 209,462 | +4.2% | 0.02% | -22.2% |
| Q4 2022 | $10,245 | -99.9% | 201,008 | -24.4% | 0.03% | -35.7% |
| Q3 2022 | $14,319,000 | -16.9% | 265,850 | -0.9% | 0.04% | -12.5% |
| Q2 2022 | $17,226,000 | -19.9% | 268,196 | -3.3% | 0.05% | -9.4% |
| Q1 2022 | $21,500,000 | -6.4% | 277,323 | +3.6% | 0.05% | -1.9% |
| Q4 2021 | $22,970,000 | +6.5% | 267,584 | -0.2% | 0.05% | -1.8% |
| Q3 2021 | $21,563,000 | +3.8% | 268,106 | +3.9% | 0.06% | +1.9% |
| Q2 2021 | $20,774,000 | -4.5% | 258,059 | +0.0% | 0.05% | -11.5% |
| Q1 2021 | $21,764,000 | +9.7% | 258,050 | +4.4% | 0.06% | +3.4% |
| Q4 2020 | $19,841,000 | -2.4% | 247,275 | -2.1% | 0.06% | -15.7% |
| Q3 2020 | $20,319,000 | +17.9% | 252,656 | +26.3% | 0.07% | +7.7% |
| Q2 2020 | $17,228,000 | +55.7% | 200,105 | +46.8% | 0.06% | +27.5% |
| Q1 2020 | $11,068,000 | -17.6% | 136,323 | -15.1% | 0.05% | +6.2% |
| Q4 2019 | $13,426,000 | -13.2% | 160,563 | -9.2% | 0.05% | -21.3% |
| Q3 2019 | $15,471,000 | +6.7% | 176,875 | -0.0% | 0.06% | +8.9% |
| Q2 2019 | $14,493,000 | +16.0% | 176,963 | +15.0% | 0.06% | -23.3% |
| Q1 2019 | $12,491,000 | +46.3% | 153,940 | +18.7% | 0.07% | +25.9% |
| Q4 2018 | $8,537,000 | +6.1% | 129,711 | +25.4% | 0.06% | +16.0% |
| Q3 2018 | $8,048,000 | +14.8% | 103,467 | +8.9% | 0.05% | +4.2% |
| Q2 2018 | $7,009,000 | +11.4% | 95,009 | -1.8% | 0.05% | +9.1% |
| Q1 2018 | $6,294,000 | -14.3% | 96,777 | -14.9% | 0.04% | -15.4% |
| Q4 2017 | $7,348,000 | +3.9% | 113,681 | +0.8% | 0.05% | -1.9% |
| Q3 2017 | $7,074,000 | +4.1% | 112,729 | +0.5% | 0.05% | 0.0% |
| Q2 2017 | $6,793,000 | +20.7% | 112,205 | +3.4% | 0.05% | +15.2% |
| Q1 2017 | $5,628,000 | +12.7% | 108,514 | -3.6% | 0.05% | +7.0% |
| Q4 2016 | $4,993,000 | -5.5% | 112,604 | +1.4% | 0.04% | -8.5% |
| Q3 2016 | $5,284,000 | -1.0% | 111,012 | -3.3% | 0.05% | -4.1% |
| Q2 2016 | $5,338,000 | +10.0% | 114,768 | -2.8% | 0.05% | +6.5% |
| Q1 2016 | $4,851,000 | -4.9% | 118,096 | -11.7% | 0.05% | -9.8% |
| Q4 2015 | $5,100,000 | +14.7% | 133,672 | -1.3% | 0.05% | +8.5% |
| Q3 2015 | $4,448,000 | -66.4% | 135,395 | -28.5% | 0.05% | -63.8% |
| Q2 2015 | $13,233,000 | – | 189,233 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |